Guggenheim Maintains Endava(DAVA.US) With Buy Rating, Cuts Target Price to $45
Morgan Stanley Maintains Endava(DAVA.US) With Hold Rating, Maintains Target Price $35
Endava Is Maintained at Overweight by JP Morgan
Endava Analyst Ratings
Morgan Stanley Maintains Endava(DAVA.US) With Hold Rating, Maintains Target Price $35
J.P. Morgan Maintains Endava(DAVA.US) With Buy Rating, Raises Target Price to $47
Morgan Stanley Maintains Endava(DAVA.US) With Hold Rating, Maintains Target Price $35
Morgan Stanley Maintains Endava(DAVA.US) With Hold Rating, Maintains Target Price $35
Morgan Stanley Remains a Hold on Endava (DAVA)
Morgan Stanley Maintains Endava(DAVA.US) With Hold Rating, Maintains Target Price $35
Analysts Offer Insights on Technology Companies: Nutanix (NTNX), Endava (DAVA) and Karooooo (KARO)
Morgan Stanley Keeps Their Hold Rating on Endava (DAVA)
Morgan Stanley Maintains Endava(DAVA.US) With Hold Rating, Maintains Target Price $35
Morgan Stanley Maintains Endava(DAVA.US) With Hold Rating, Maintains Target Price $35
Analysts Offer Insights on Technology Companies: Karooooo (KARO), Science Applications (SAIC) and Endava (DAVA)
Endava (DAVA) Receives a Hold From Morgan Stanley
Wedbush Lowers Price Target on Endava to $37 From $50 After Mixed Fiscal Q3 Results, Maintains Outperform Rating
Endava Analyst Ratings
Guggenheim Maintains Buy on Endava, Lowers Price Target to $55
JPMorgan Adjusts Price Target on Endava to $41 From $43, Maintains Overweight Rating